Coinbase Adds BIO and EUL to Listing Roadmap, Triggering Volatile Price Reactions

On July 29, 2025, Coinbase announced via X that it added Bio Protocol (BIO) and Euler (EUL) to its asset roadmap, signaling potential future listings. This triggered immediate but divergent price reactions: BIO surged nearly 17% initially before paring gains, while EUL spiked 22.22% to $16.50 before retreating to $13.52 (+0.17%) at press time according to market data.

Bio Protocol's BIO token powers a decentralized science (DeSci) ecosystem focused on tokenizing scientific intellectual property through BioDAOs. Euler's EUL serves as the governance token for Euler Finance, an Ethereum-based lending protocol specializing in long-tailed crypto assets. Both tokens are already listed on major exchanges including Binance, Kraken, and KuCoin, which analysts suggest may moderate the impact of a potential Coinbase listing.

Coinbase explicitly cautioned that roadmap inclusion doesn't guarantee listing, noting requirements for market-making support and technical infrastructure. The exchange highlighted historical volatility patterns - while tokens like ResearchCoin (RSC) surged 82% after similar announcements, others like Newton Protocol's NEWT crashed 44% post-listing due to profit-taking sell pressure.